{"count": 1, "results": [{"_id": "39676223", "pmid": 39676223, "title": "Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial.", "journal": "J Psychopharmacol", "authors": ["Bazrafshan Z", "Mohammadi P", "Hasanzadeh A", "Sanjari Moghaddam M", "Kabiri M", "Sanjari Moghaddam H", "Abdolghaffari AH", "Mohammadi MR", "Akhondzadeh S"], "date": "2024-12-15T00:00:00Z", "doi": "10.1177/02698811241303593", "meta_date_publication": "2024 Dec 15", "meta_volume": "", "meta_issue": "", "meta_pages": "2698811241303593", "score": 50245.375, "text_hl": "Among the other four subscales of ABC-C, the @DISEASE_Hyperkinesis @DISEASE_MESH:D006948 @@@hyperactivity@@@/noncompliance score showed a significant drop during the baseline-to-week-5 period (p = 0.021). In addition, @<m>DISEASE_Speech_Disorders</m> @DISEASE_MESH:D013064 @@@inappropriate speech@@@ subscales decreased significantly from baseline-to-week 5 in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ compared to the placebo group (p = 0.045). ", "citations": {"NLM": "Bazrafshan Z, Mohammadi P, Hasanzadeh A, Sanjari Moghaddam M, Kabiri M, Sanjari Moghaddam H, Abdolghaffari AH, Mohammadi MR, Akhondzadeh S. Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 2024 Dec 15;():2698811241303593. PMID: 39676223", "BibTeX": "@article{39676223, title={Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial.}, author={Bazrafshan Z and Mohammadi P and Hasanzadeh A and Sanjari Moghaddam M and Kabiri M and Sanjari Moghaddam H and Abdolghaffari AH and Mohammadi MR and Akhondzadeh S}, journal={J Psychopharmacol}, pages={2698811241303593}}"}}]}